Picture of Cohance Lifesciences logo

COHANCE — Cohance Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Suven Pharmaceuticals' Unit Casper Pharma Receives EIR From USFDA For Pre-Approval Inspection

Oct 4 (Reuters) - Suven Pharmaceuticals Ltd  SUVH.NS :
    * CASPER PHARMA RECEIVED EIR FROM USFDA FOR PRE-APPROVAL
INSPECTION

Further company coverage:  SUVH.NS 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Cohance Lifesciences

See all news